| Novartis Pharma Schweiz AG - Sandostatin 0,5 mg/mL, Injektionslösung | | 49137 | | 04 | | Sandostatin 0,5 mg/mL | | Injektionslösung | | H01CB02 | | Octreotide | | 22.03.1991 | | |
| | Composition | | octreotidum 0.5 mg ut octreotidi acetas, mannitolum, acidum lacticum, natrii hydrogenocarbonas q.s. ad pH, aqua ad iniectabile ad solutionem pro 1 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Octreotide | 0.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Octreotide | 0.5 mg |
| | | | Inactive agents |
|---|
| Lactic Acid | | Mannitol | | Sodium Hydrogen Carbonate |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 079 | 5 1 ampoule(s) à 1 ml | 227.65 | 262.60 | A | SL | No |
|
|
